COVID-19 合并急性冠状动脉综合征患者的经皮冠状动脉介入治疗：如果旧常态成为新常态怎么办？
Percutaneous coronary intervention in patients with COVID-19 and acute coronary syndrome: What if the old normal became the new normal?
机构信息
Division of Cardiology, Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.
UNESCO Chair on Health Education and Sustainable Development, University of Naples Federico II, Naples, Italy.
出版信息
Catheter Cardiovasc Interv. 2021 Feb 1;97(2):199-200. doi: 10.1002/ccd.29480.
Abstract
The management of COVID‐19 patients with acute coronary syndrome (ACS) remains challenging. This initial experience supports the safety and efficacy of invasive assessment in patients with COVID‐19 and ACS as well as the safety of the procedure for healthcare personnel. The study findings raise the question of whether we should continue to follow “COVID‐19 guidelines” suggesting a more conservative approach to ACS patients with COVID‐19 or rather go back to a more unrestricted use of invasive angiography and revascularization.
摘要
管理 COVID-19 合并急性冠状动脉综合征（ACS）患者仍然具有挑战性。这一初步经验支持对 COVID-19 合并 ACS 患者进行有创评估的安全性和有效性，以及对医护人员来说该操作的安全性。研究结果提出了一个问题，即我们是否应该继续遵循“COVID-19 指南”，建议对 COVID-19 合并 ACS 患者采取更为保守的方法，还是恢复更广泛地使用有创血管造影和血运重建。
相似文献
1
Percutaneous coronary intervention in patients with COVID-19 and acute coronary syndrome: What if the old normal became the new normal?COVID-19 合并急性冠状动脉综合征患者的经皮冠状动脉介入治疗：如果旧常态成为新常态怎么办？
Catheter Cardiovasc Interv. 2021 Feb 1;97(2):199-200. doi: 10.1002/ccd.29480.
2
Population Trends in Rates of Percutaneous Coronary Revascularization for Acute Coronary Syndromes Associated With the COVID-19 Outbreak.与COVID-19疫情相关的急性冠状动脉综合征经皮冠状动脉血运重建率的人群趋势
Circulation. 2020 Jun 16;141(24):2035-2037. doi: 10.1161/CIRCULATIONAHA.120.047457. Epub 2020 Apr 30.
3
How has COVID-19 impacted the care of patients with acute coronary syndromes?新型冠状病毒肺炎（COVID-19）如何影响急性冠状动脉综合征患者的护理？
Expert Rev Cardiovasc Ther. 2023 Jan;21(1):1-4. doi: 10.1080/14779072.2023.2159809. Epub 2022 Dec 26.
4
Clinical Impact of Suboptimal Stenting and Residual Intrastent Plaque/Thrombus Protrusion in Patients With Acute Coronary Syndrome: The CLI-OPCI ACS Substudy (Centro per la Lotta Contro L'Infarto-Optimization of Percutaneous Coronary Intervention in Acute Coronary Syndrome).急性冠状动脉综合征患者支架置入不达标及支架内残余斑块/血栓突出的临床影响：CLI-OPCI ACS子研究（急性冠状动脉综合征经皮冠状动脉介入治疗优化中心）
Circ Cardiovasc Interv. 2016 Dec;9(12). doi: 10.1161/CIRCINTERVENTIONS.115.003726.
5
Decrease and Delay in Hospitalization for Acute Coronary Syndromes During the 2020 SARS-CoV-2 Pandemic.2020 年 SARS-CoV-2 大流行期间急性冠状动脉综合征住院人数减少和延迟。
Can J Cardiol. 2020 Jul;36(7):1152-1155. doi: 10.1016/j.cjca.2020.05.023. Epub 2020 May 22.
6
Impact of the COVID-19 pandemic on coronary invasive procedures at two Italian high-volume referral centers.COVID-19 大流行对两家意大利高容量转诊中心的冠状动脉介入治疗的影响。
J Cardiovasc Med (Hagerstown). 2020 Nov;21(11):869-873. doi: 10.2459/JCM.0000000000001101.
7
Clinical and procedural characteristics of COVID-19 patients treated with percutaneous coronary interventions.经皮冠状动脉介入治疗的 COVID-19 患者的临床和操作特点。
Catheter Cardiovasc Interv. 2020 Nov;96(6):E568-E575. doi: 10.1002/ccd.29134. Epub 2020 Jul 20.
8
Fast-track ruling in/out SARS-CoV-2 infection with rapid 0/1.5 h molecular test in patients with acute coronary syndromes.快速 0/1.5 小时分子检测对急性冠脉综合征患者进行 SARS-CoV-2 感染的快速排除/纳入诊断。
J Cardiovasc Med (Hagerstown). 2020 Dec;21(12):975-979. doi: 10.2459/JCM.0000000000001117.
9
Revascularization strategy in patients with acute ST-elevation myocardial infarction amid COVID-19 pandemic.2019冠状病毒病大流行期间急性ST段抬高型心肌梗死患者的血运重建策略
J Formos Med Assoc. 2021 Jan;120(1 Pt 3):772-773. doi: 10.1016/j.jfma.2020.07.041. Epub 2020 Aug 4.
10
Acute coronary syndromes during COVID-19.新型冠状病毒肺炎期间的急性冠状动脉综合征
Eur Heart J. 2020 Jun 7;41(22):2047-2049. doi: 10.1093/eurheartj/ehaa457.
引用本文的文献
1
COVID-19-Related Pathologies in Coronary Angiography in Patients with Acute Coronary Syndromes.急性冠状动脉综合征患者冠状动脉造影中与 COVID-19 相关的病变
J Clin Med. 2025 May 23;14(11):3672. doi: 10.3390/jcm14113672.
2
Effect of ticagrelor combined with metoprolol extended-release tablets on cardiac function and clinical prognosis in elderly patients with acute coronary syndrome after percutaneous coronary intervention.替格瑞洛联合美托洛尔缓释片对老年急性冠状动脉综合征患者经皮冠状动脉介入治疗后心功能及临床预后的影响
Front Cardiovasc Med. 2025 Jan 28;12:1492569. doi: 10.3389/fcvm.2025.1492569. eCollection 2025.
3
An In-Depth Insight into Clinical, Cellular and Molecular Factors in COVID19-Associated Cardiovascular Ailments for Identifying Novel Disease Biomarkers, Drug Targets and Clinical Management Strategies.深入洞察新冠病毒相关心血管疾病的临床、细胞和分子因素，以确定新型疾病生物标志物、药物靶点和临床管理策略。
Arch Microbiol Immunol. 2024;8(3):290-308. doi: 10.26502/ami.936500177. Epub 2024 Jul 19.
本文引用的文献
1
Coronary artery disease in patients hospitalised with Coronavirus disease 2019 (COVID-19) infection.2019冠状病毒病（COVID-19）感染住院患者的冠状动脉疾病
Open Heart. 2020 Nov;7(2). doi: 10.1136/openhrt-2020-001428.
2
Invasive strategy for COVID patients presenting with acute coronary syndrome: The first multicenter Italian experience.急性冠脉综合征合并 COVID-19 患者的侵入性治疗策略：意大利的首个多中心经验。
Catheter Cardiovasc Interv. 2021 Feb 1;97(2):195-198. doi: 10.1002/ccd.28959. Epub 2020 May 12.
3
Population Trends in Rates of Percutaneous Coronary Revascularization for Acute Coronary Syndromes Associated With the COVID-19 Outbreak.与COVID-19疫情相关的急性冠状动脉综合征经皮冠状动脉血运重建率的人群趋势
Circulation. 2020 Jun 16;141(24):2035-2037. doi: 10.1161/CIRCULATIONAHA.120.047457. Epub 2020 Apr 30.
4
Management of acute myocardial infarction during the COVID-19 pandemic: A Consensus Statement from the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP).COVID-19 大流行期间急性心肌梗死的管理：心血管血管造影和介入学会（SCAI）、美国心脏病学会（ACC）和美国急诊医师学会（ACEP）的共识声明。
Catheter Cardiovasc Interv. 2020 Aug;96(2):336-345. doi: 10.1002/ccd.28946. Epub 2020 May 13.
5
Italian Society of Interventional Cardiology (GISE) position paper for Cath lab-specific preparedness recommendations for healthcare providers in case of suspected, probable or confirmed cases of COVID-19.意大利介入心脏病学会（GISE）关于疑似、可能或确诊 COVID-19 病例情况下医疗保健提供者的导管实验室特定准备建议的立场文件。
Catheter Cardiovasc Interv. 2020 Oct 1;96(4):839-843. doi: 10.1002/ccd.28888. Epub 2020 Apr 11.
Zotero 插件